{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T06:47:25Z","timestamp":1782283645122,"version":"3.54.5"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>We and others demonstrated that the natural compound Alternol induces apoptosis preferentially in human cancer cells. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) participates in cellular glycolysis, important for energy homeostasis, especially in cancer cells. We recently discovered that Alternol interacts with GAPDH, along with 4 Krebs cycle enzymes. In this study, we characterized the mechanism for Alternol-GAPDH interaction and the functional significance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Multiple human prostate cancer cell lines and a benign prostate epithelial cell line were utilized in the experiments. Enzyme activity assay\n                      <jats:italic>in vitro<\/jats:italic>\n                      with purified protein was used to examine Alternol inhibition of GAPDH activity. Computer-based docking assessment was performed to analyze Alternol interaction with GAPDH protein. Seahorse instrument was used to conduct glycolytic testing.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Our data revealed that Alternol interacts with GAPDH protein on two sites, one of which is the NAD\n                      <jats:sup>+<\/jats:sup>\n                      binding site on the active domain of the enzyme, postulating an inhibitory effect. As expected, Alternol directly inhibited GAPDH dehydrogenase activity in an\n                      <jats:italic>in vitro<\/jats:italic>\n                      assay with purified enzyme with nanomole IC50 value at 5.794 nM. Consistently, Alternol significantly suppressed its enzymatic activity in cultured cancer cells but not in benign cells. These inhibitory effects were associated with reduced glycolytic capacity in cancer cells as assessed by extracellular acidification rate (ECAR) and metabolomic analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These results suggest that Alternol potently inhibits GAPDH activity and specifically disrupts glycolytic flux in cancer cells.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1895065","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:55:51Z","timestamp":1782280551000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Alternol inhibits GAPDH activity and disrupts glycolytic flux preferentially in cancer cells"],"prefix":"10.3389","volume":"17","author":[{"given":"Yuelong","family":"Chai","sequence":"first","affiliation":[{"name":"Department of Plastic Surgery, The Affiliated Hospital, Guangdong Medical University","place":["Zhanjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Urology, The University of Kansas Medical Center","place":["Kansas City, KS, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moben","family":"Mirza","sequence":"additional","affiliation":[{"name":"Department of Urology, The University of Kansas Medical Center","place":["Kansas City, KS, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Radiation & Medical Oncology, The Second Affiliated Hospital of Wenzhou Medical University","place":["Wenzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benyi","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Urology, The University of Kansas Medical Center","place":["Kansas City, KS, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/metabo9030057","article-title":"MetaboAnalystR 2.0: from raw spectra to biological insights","volume":"9","author":"Chong","year":"2019","journal-title":"Metabolites"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1242\/jcs.114.9.1643","article-title":"Potential role of nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase in apoptosis and oxidative stress","volume":"114","author":"Dastoor","year":"2001","journal-title":"J. Cell Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/14728222.2018.1449834","article-title":"Evolution of GAPDH as a druggable target of tumor glycolysis?","volume":"22","author":"Ganapathy-Kanniappan","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"key":"B4","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/1476-4598-12-152","article-title":"Tumor glycolysis as a target for cancer therapy: progress and prospects","volume":"12","author":"Ganapathy-Kanniappan","year":"2013","journal-title":"Mol. Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"940","DOI":"10.18632\/oncotarget.623","article-title":"Glyceraldehyde-3-phosphate dehydrogenase: a promising target for molecular therapy in hepatocellular carcinoma","volume":"3","author":"Ganapathy-Kanniappan","year":"2012","journal-title":"Oncotarget"},{"key":"B6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.bbcan.2016.06.005","article-title":"Glycolysis inhibition as a cancer treatment and its role in an anti-tumour immune response","volume":"1866","author":"Gill","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"B7","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B8","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/ncb1268","article-title":"S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding","volume":"7","author":"Hara","year":"2005","journal-title":"Nat. Cell Biol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1002\/pros.23377","article-title":"Characterization of a novel p110beta-specific inhibitor BL140 that overcomes MDV3100-resistance in castration-resistant prostate cancer cells","volume":"77","author":"He","year":"2017","journal-title":"Prostate"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1107\/S0907444905026740","article-title":"Structural analysis of human liver glyceraldehyde-3-phosphate dehydrogenase","volume":"61","author":"Ismail","year":"2005","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"B11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0167-4838(92)90431-c","article-title":"Koningic acid (heptelidic acid) inhibition of glyceraldehyde-3-phosphate dehydrogenases from various sources","volume":"1120","author":"Kato","year":"1992","journal-title":"Biochim. Biophys. Acta"},{"key":"B12","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/yea.3367","article-title":"3-Bromopyruvate as a potent anticancer therapy in honor and memory of the late professor andre goffeau","volume":"36","author":"Ko","year":"2019","journal-title":"Yeast"},{"key":"B13","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1517\/14728222.2013.775253","article-title":"Deregulation of glycolysis in cancer: Glyceraldehyde-3-phosphate dehydrogenase as a therapeutic target","volume":"17","author":"Krasnov","year":"2013","journal-title":"Expert Opin. Ther. Targets"},{"key":"B14","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.bbrc.2007.10.199","article-title":"Glucose-dependent active ATP depletion by koningic acid kills high-glycolytic cells","volume":"365","author":"Kumagai","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1196\/annals.1333.017","article-title":"Methylglyoxal can modify GAPDH activity and structure","volume":"1043","author":"Lee","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/pros.23767","article-title":"Alternol eliminates excessive ATP production by disturbing krebs cycle in prostate cancer","volume":"79","author":"Li","year":"2019","journal-title":"Prostate"},{"key":"B17","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.cmet.2017.08.017","article-title":"A predictive model for selective targeting of the warburg effect through GAPDH inhibition with a natural product","volume":"26","author":"Liberti","year":"2017","journal-title":"Cell Metab."},{"key":"B18","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/CCO.0000000000000518","article-title":"PET imaging in renal cancer","volume":"31","author":"Lindenberg","year":"2019","journal-title":"Curr. Opin. Oncol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s11010-007-9560-0","article-title":"Alternol inhibits proliferation and induces apoptosis in mouse lymphocyte leukemia (L1210) cells","volume":"306","author":"Liu","year":"2007","journal-title":"Mol. Cell Biochem."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1007\/s00709-017-1095-y","article-title":"Physiology, phylogeny, early evolution, and GAPDH","volume":"254","author":"Martin","year":"2017","journal-title":"Protoplasma"},{"key":"B21","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.1233606","article-title":"Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay","volume":"341","author":"Martinez Molina","year":"2013","journal-title":"Science"},{"key":"B22","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.bbabio.2014.10.005","article-title":"The contributions of respiration and glycolysis to extracellular acid production","volume":"1847","author":"Mookerjee","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"B23","doi-asserted-by":"publisher","first-page":"4727","DOI":"10.1074\/jbc.M116.759084","article-title":"Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) aggregation causes mitochondrial dysfunction during oxidative stress-induced cell death","volume":"292","author":"Nakajima","year":"2017","journal-title":"J. Biol. Chem."},{"key":"B24","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.neuint.2012.05.017","article-title":"Decreased oxidative stress during glycolytic inhibition enables maintenance of ATP production and astrocytic survival","volume":"61","author":"Nodin","year":"2012","journal-title":"Neurochem. Int."},{"key":"B25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The emerging hallmarks of cancer metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab."},{"key":"B26","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1042\/BJ20080805","article-title":"Inhibition of energy-producing pathways of HepG2 cells by 3-bromopyruvate","volume":"417","author":"Pereira da Silva","year":"2009","journal-title":"Biochem. J."},{"key":"B27","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1432-1033.1990.tb19323.x","article-title":"Two glyceraldehyde-3-phosphate dehydrogenase isozymes from the koningic acid (heptelidic acid) producer Trichoderma koningii","volume":"193","author":"Sakai","year":"1990","journal-title":"Eur. J. Biochem."},{"key":"B28","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/0167-4838(91)90058-8","article-title":"Identification of koningic acid (Heptelidic acid)-modified site in rabbit muscle glyceraldehyde-3-phosphate dehydrogenase","volume":"1077","author":"Sakai","year":"1991","journal-title":"Biochim. Biophys. Acta"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e03342","DOI":"10.7554\/eLife.03342","article-title":"Quantitative determinants of aerobic glycolysis identify flux through the enzyme GAPDH as a limiting step","volume":"3","author":"Shestov","year":"2014","journal-title":"Elife"},{"key":"B30","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s10555-018-9764-7","article-title":"Pleiotropic effects of moonlighting glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in cancer progression, invasiveness, and metastases","volume":"37","author":"Sirover","year":"2018","journal-title":"Cancer Metastasis Rev."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1158\/1535-7163.MCT-13-0981","article-title":"Natural compound alternol induces oxidative stress-dependent apoptotic cell death preferentially in prostate cancer cells","volume":"13","author":"Tang","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"B32","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cellsig.2010.08.003","article-title":"The diverse functions of GAPDH: views from different subcellular compartments","volume":"23","author":"Tristan","year":"2011","journal-title":"Cell Signal"},{"key":"B33","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1083\/jcb.200910083","article-title":"Dual action of epidermal growth factor: extracellular signal-stimulated nuclear-cytoplasmic export and coordinated translation of selected messenger RNA","volume":"188","author":"Tsai","year":"2010","journal-title":"J. Cell Biol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"5862","DOI":"10.1073\/pnas.0307476101","article-title":"Identification of GAPDH as a protein target of the saframycin antiproliferative agents","volume":"101","author":"Xing","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B35","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/pros.21417","article-title":"Alternol exerts prostate-selective antitumor effects through modulations of the AMPK signaling pathway","volume":"72","author":"Yeung","year":"2012","journal-title":"Prostate"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1126\/science.aaa5004","article-title":"Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH","volume":"350","author":"Yun","year":"2015","journal-title":"Science"},{"key":"B37","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/978-1-4939-9027-6_18","article-title":"Using seahorse machine to measure OCR and ECAR in cancer cells","volume":"1928","author":"Zhang","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7497\/j.issn.2095-3941.2014.0019","article-title":"Critical protein GAPDH and its regulatory mechanisms in cancer cells","volume":"12","author":"Zhang","year":"2015","journal-title":"Cancer Biol. Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1895065\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:55:53Z","timestamp":1782280553000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1895065\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":38,"alternative-id":["10.3389\/fphar.2026.1895065"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1895065","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"article-number":"1895065"}}